SR 57227A is a partial agonist/partial antagonist of 5-HT3 receptor and inhibits subsequent 5-HT- or SR 57227A-induced 5-HT3 receptor current.
SR 57227A is a partial agonist/partial antagonist of 5-HT3 receptor and inhibits subsequent 5-HT- or SR 57227A-induced 5-HT3 receptor current.
复制标题
SR 57227A 是 5-HT3 受体的部分激动剂/部分拮抗剂,并抑制随后的 5-HT 或 SR 57227A 诱导的 5-HT3 受体电流。
DOI:
10.1016/j.bbrc.2018.11.174
复制
发表时间:
2019
影响因子:
3.1
通讯作者:
Shimada S.
中科院分区:
文献类型:
--
作者:
Nakamura Y;Kondo M;Koyama Y;Shimada S.
The serotonin (5-hydroxytryptamine) type 3 (5-HT3) receptors are transmembrane ligand-gated ion channels. Although several 5-HT3receptor agonists have been used as preclinical tools, SR 57227A is the most commonly used 5-HT3receptor agonist with the ability to cross the blood brain barrier. However, the precise pharmacological profile of SR 57227A remains unclear. Therefore, we examined the pharmacological profile of SR 57227A at the 5-HT3A and 5-HT3AB receptors. We microinjectedXenopus laevisoocytes with human 5-HT3A complementary RNA (cRNA) or a combination of human 5-HT3A and human 5-HT3AB cRNA and performed two electrode voltage clamp recordings of 5-HT3A and 5-HT3AB receptor current in the presence of SR 57227A. Results showed that SR 57227A acts as partial agonist/partial antagonist at the 5-HT3receptor. Interestingly, SR 57227A specifically reduced subsequent current amplitudes induced by 5-HT or SR 57227A. Based on its 5-HT3receptor partial agonist/partial antagonist properties, we predict that SR 57227A functions as a serotonin stabilizer.